About Eskag Pharma
Eskag Pharma is a company based in Kolkata (India) founded in 1972 by Anup Bannerjee. It operates as a B2B and Manufacturing. The company has 594 employees as of March 31, 2024. Eskag Pharma offers products and services including Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml. Eskag Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Kolkata, India
- Employees 594 as on 31 Mar, 2024
- Founders Anup Bannerjee
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eskag Pharma Pvt Ltd
- Date of Incorporation 24 Feb, 1977
- Jurisdiction Kolkata, West Bengal, India
-
Annual Revenue
$8.96 M (USD)0.12as on Mar 31, 2024
-
Net Profit
$828.71 K (USD)-30.54as on Mar 31, 2024
-
EBITDA
$1.53 M (USD)-25.53as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
594
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eskag Pharma
Eskag Pharma offers a comprehensive portfolio of products and services, including Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml.
Oral laxative for constipation relief and digestive health support.
Tablets for managing gynaecological conditions effectively.
Medication combining antibiotics for infection treatment.
Iron replenishment formulation for rapid health restoration.
Polyethylene glycol liquid for pediatric laxative use.
Funding Insights of Eskag Pharma
Detailed funding history for Eskag Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eskag Pharma
Investment portfolio details for Eskag Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eskag Pharma
Detailed financials for Eskag Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eskag Pharma Comparisons
Peer comparison for Eskag Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eskag Pharma
Eskag Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Eskag Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eskag Pharma
Complete news archive for Eskag Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eskag Pharma
Eskag Pharma was founded in 1972.
Eskag Pharma is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Anup Bannerjee is the current CEO of Eskag Pharma. They have also founded this company.
As of Mar 31, 2024, the latest employee count at Eskag Pharma is 594.
Annual revenue of Eskag Pharma is $8.96M as on Mar 31, 2024.
Eskag Pharma Pvt. Ltd. is a leading pharmaceutical manufacturer in India, producing high-quality medications for various therapeutic areas including gastroenterology, pediatrics, and gynaecology. They operate through research-driven formulations and third-party manufacturing, exporting to over 20 countries. Based in Kolkata and Haridwar, they prioritize innovation, quality control, and global supply chains to serve healthcare professionals and distributors effectively.
Eskag Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Eskag Pharma offers Relux L, Tribs, Tinicline, FeCM Injection, and Relux 100ml.